Because treatment of the whole prostate can lead to long-term side effects in patients with prostate cancer, interest in ...

LUPRON DEPOT (leuprolide acetate for extended-release injectable suspension) is a hormonal medication first approved by Health Canada in 1989 for advanced prostate cancer, and later for various ...

Decades ago, doctors created a test to determine which breast cancer patients should receive hormone therapy. Now, ...

A PSA of 127 indicated a high probability of prostate cancer, leading to immediate Lupron ADT therapy and radiation treatment. Initial diagnosis and treatment left the author feeling weak and ...